[HTML][HTML] The Streptococcus pyogenes hyaluronic acid capsule promotes experimental nasal and skin infection by preventing neutrophil-mediated clearance
JR Hurst, BA Shannon, HC Craig, A Rishi… - PLoS …, 2022 - journals.plos.org
Streptococcus pyogenes is a globally prominent human-specific pathogen responsible for
an enormous burden of human illnesses, including> 600 million pharyngeal and> 100 …
an enormous burden of human illnesses, including> 600 million pharyngeal and> 100 …
Asymptomatic carriage of group A Streptococcus is associated with elimination of capsule production
Humans commonly carry pathogenic bacteria asymptomatically, but despite decades of
study, the underlying molecular contributors remain poorly understood. Here, we show that a …
study, the underlying molecular contributors remain poorly understood. Here, we show that a …
Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements
M Falaleeva, OW Zurek, RL Watkins… - Infection and …, 2014 - Am Soc Microbiol
The important human pathogen Streptococcus pyogenes (group A Streptococcus [GAS])
produces a hyaluronic acid (HA) capsule that plays critical roles in immune evasion …
produces a hyaluronic acid (HA) capsule that plays critical roles in immune evasion …
Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells
S Kawabata, H Kuwata, I Nakagawa, S Morimatsu… - Microbial …, 1999 - Elsevier
Group A streptococci (GAS) cause various diseases, from uncomplicated noninvasive, to
severe invasive infections. Capsular hyaluronic acid (HA) is known to resist phagocytosis …
severe invasive infections. Capsular hyaluronic acid (HA) is known to resist phagocytosis …
Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia
LK Husmann, DL Yung, SK Hollingshead… - Infection and …, 1997 - Am Soc Microbiol
To investigate the role of putative virulence factors of Streptococcus pyogenes (group A
streptococcus; GAS) in causing disease, we introduced specific mutations in GAS strain …
streptococcus; GAS) in causing disease, we introduced specific mutations in GAS strain …
Detoxification of reactive oxygen species by the hyaluronic acid capsule of group A Streptococcus
S Wilde, A Dash, A Johnson, K Mackey… - Infection and …, 2023 - Am Soc Microbiol
The pro-inflammatory cytokine IL-6 regulates antimicrobial responses that are broadly
crucial in the defense against infection. Our prior work shows that IL-6 promotes the killing of …
crucial in the defense against infection. Our prior work shows that IL-6 promotes the killing of …
[HTML][HTML] Hyaluronan breakdown contributes to immune defense against group A Streptococcus
Group A Streptococcus (GAS) commonly infects human skin and occasionally causes
severe and life-threatening invasive diseases. The hyaluronan (HA) capsule of GAS has …
severe and life-threatening invasive diseases. The hyaluronan (HA) capsule of GAS has …
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection
I Gryllos, C Cywes, MH Shearer, M Cary… - Molecular …, 2001 - Wiley Online Library
Capsular polysaccharide production by group A Streptococcus (GAS) is controlled by
transcription of the has operon that encodes the enzymes uniquely required for synthesis of …
transcription of the has operon that encodes the enzymes uniquely required for synthesis of …
Capsule of Streptococcus equi subsp. zooepidemicus hampers the adherence and invasion of epithelial and endothelial cells and is attenuated during …
B Xu, X Pei, Y Su, Z Ma, H Fan - FEMS Microbiology Letters, 2016 - academic.oup.com
Direct interaction between pathogens and host cells often is a prerequisite for colonization,
infection and dissemination. Regulated production of capsular polysaccharide (CPS), which …
infection and dissemination. Regulated production of capsular polysaccharide (CPS), which …
Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II‐dependent pathway for antigen presentation
Some pathogenic bacteria form thick capsules that both block immune responses through
inhibition of complement deposition and phagocytosis and stimulate a weak response …
inhibition of complement deposition and phagocytosis and stimulate a weak response …